Statins 	Statins 	 NNP	B-NP
,  	,  	 ,	O
fracture  	fracture  	 JJ	B-NP
risk 	risk 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
bone  	bone  	 NN	B-NP
remodeling  	remodeling  	 NN	I-NP
Statins  	Statins  	 NNS	I-NP
inhibit  	inhibit  	 VBP	O
HMG-CoA  	HMG-CoA  	 JJ	B-NP
reductase  	reductase  	 NN	I-NP
and  	and  	 CC	O
reduce  	reduce  	 VB	O
the  	the  	 DT	O
intracellular  	intracellular  	 JJ	B-NP
formation  	formation  	 NN	I-NP
of  	of  	 IN	I-NP
mevalonate 	mevalonate 	 NN	I-NP
.  	.  	 .	O
They  	They  	 PRP	O
are  	are  	 VBP	O
chemical  	chemical  	 JJ	B-NP
compounds  	compounds  	 JJ	I-NP
able  	able  	 JJ	O
to  	to  	 TO	O
reduce  	reduce  	 VB	O
total  	total  	 JJ	B-NP
cholesterol  	cholesterol  	 NN	I-NP
by  	by  	 IN	O
15-40 	15-40 	 CD	O
%  	%  	 NN	O
and  	and  	 CC	O
LDL  	LDL  	 NNP	B-NP
cholesterol  	cholesterol  	 NN	I-NP
by  	by  	 IN	O
20-60 	20-60 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
to  	to  	 TO	O
increase  	increase  	 VB	O
HDL  	HDL  	 JJ	B-NP
cholesterol  	cholesterol  	 NN	I-NP
by  	by  	 IN	O
5-15 	5-15 	 CD	O
% 	% 	 NN	O
.  	.  	 .	O
They  	They  	 PRP	O
also  	also  	 RB	O
reduce  	reduce  	 VB	O
triglycerides  	triglycerides  	 VBN	O
by  	by  	 IN	O
10-  	10-  	 CD	O
30 	30 	 CD	O
% 	% 	 NN	O
.  	.  	 .	O
Statins 	Statins 	 NNP	B-NP
,  	,  	 ,	O
blocking  	blocking  	 VBG	O
the  	the  	 DT	O
mevalonate  	mevalonate  	 JJ	B-NP
pathway 	pathway 	 NN	I-NP
,  	,  	 ,	O
inhibit  	inhibit  	 VBP	O
the  	the  	 DT	O
prenylation  	prenylation  	 NN	B-NP
of  	of  	 IN	O
proteins 	proteins 	 NNS	O
,  	,  	 ,	O
which  	which  	 WDT	O
is  	is  	 VBZ	O
essential  	essential  	 JJ	O
to  	to  	 TO	O
perform  	perform  	 VB	O
their  	their  	 PRP$	O
biological  	biological  	 JJ	B-NP
function 	function 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
great  	great  	 JJ	O
deal  	deal  	 NN	O
of  	of  	 IN	O
research  	research  	 NN	O
has  	has  	 VBZ	O
documented  	documented  	 VBN	O
the  	the  	 DT	O
positive  	positive  	 JJ	B-NP
effect  	effect  	 NN	I-NP
of  	of  	 IN	I-NP
statins  	statins  	 NN	I-NP
on  	on  	 IN	O
bone  	bone  	 NN	O
formation  	formation  	 NN	O
and  	and  	 CC	O
the  	the  	 DT	O
importance  	importance  	 NN	O
of  	of  	 IN	O
bone  	bone  	 FW	B-NP
morphogenetic  	morphogenetic  	 FW	I-NP
protein-2  	protein-2  	 FW	I-NP
( 	( 	 -LRB-	O
BMP-2 	BMP-2 	 NNP	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
mediating  	mediating  	 VBG	O
this  	this  	 DT	O
effect 	effect 	 NN	O
.  	.  	 .	O
Statins  	Statins  	 NNS	B-NP
are  	are  	 VBP	O
also  	also  	 RB	O
able  	able  	 JJ	O
to  	to  	 TO	O
decrease  	decrease  	 VB	O
osteoblast  	osteoblast  	 JJ	B-NP
apoptosis 	apoptosis 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
positive  	positive  	 JJ	B-NP
effect  	effect  	 NN	I-NP
of  	of  	 IN	I-NP
statins  	statins  	 NN	I-NP
on  	on  	 IN	O
bone  	bone  	 NN	O
formation  	formation  	 NN	O
is  	is  	 VBZ	O
accompanied  	accompanied  	 VBN	O
by  	by  	 IN	O
an  	an  	 DT	O
inhibition  	inhibition  	 NN	O
of  	of  	 IN	O
osteoclast  	osteoclast  	 JJ	B-NP
activity 	activity 	 NN	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
gives  	gives  	 VBZ	O
statins  	statins  	 VBG	O
the  	the  	 DT	O
ability  	ability  	 NN	B-NP
to  	to  	 TO	O
uncouple  	uncouple  	 VB	O
the  	the  	 DT	O
bone  	bone  	 NN	O
remodeling  	remodeling  	 NN	O
processes 	processes 	 NNS	O
.  	.  	 .	O
Patients  	Patients  	 NNS	O
taking  	taking  	 VBG	O
statins  	statins  	 NNS	B-NP
have  	have  	 VBP	O
a  	a  	 DT	O
higher  	higher  	 JJR	O
femoral  	femoral  	 JJ	B-NP
bone  	bone  	 NN	I-NP
density  	density  	 NN	I-NP
than  	than  	 IN	O
those  	those  	 DT	O
who  	who  	 WP	O
do  	do  	 VBP	O
not 	not 	 RB	O
.  	.  	 .	O
The  	The  	 DT	O
lipophilic  	lipophilic  	 JJ	B-NP
statins  	statins  	 NNS	I-NP
seem  	seem  	 VBP	O
to  	to  	 TO	O
be  	be  	 VB	O
more  	more  	 RBR	O
effective  	effective  	 JJ	O
than  	than  	 IN	O
the  	the  	 DT	O
hydrophilic  	hydrophilic  	 JJ	B-NP
statins  	statins  	 NN	I-NP
in  	in  	 IN	O
protecting  	protecting  	 VBG	B-NP
bone 	bone 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
several  	several  	 JJ	O
clinical  	clinical  	 JJ	B-NP
trials 	trials 	 NNS	I-NP
,  	,  	 ,	O
but  	but  	 CC	O
not  	not  	 RB	O
in  	in  	 IN	O
all 	all 	 DT	O
,  	,  	 ,	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
statins  	statins  	 NN	B-NP
had  	had  	 VBD	O
been  	been  	 VBN	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
reduction  	reduction  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
fracture  	fracture  	 JJ	B-NP
risk 	risk 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
conclusion 	conclusion 	 NN	O
,  	,  	 ,	O
statins  	statins  	 NNS	B-NP
have  	have  	 VBP	O
a  	a  	 DT	O
positive  	positive  	 JJ	B-NP
effect  	effect  	 NN	I-NP
on  	on  	 IN	O
bone  	bone  	 NN	O
in  	in  	 IN	O
vitro 	vitro 	 NN	B-NP
,  	,  	 ,	O
but  	but  	 CC	O
such  	such  	 PDT	O
an  	an  	 DT	O
efficacy  	efficacy  	 NN	O
in  	in  	 IN	O
humans  	humans  	 NNS	O
has  	has  	 VBZ	O
yet  	yet  	 RB	O
to  	to  	 TO	O
be  	be  	 VB	O
clearly  	clearly  	 RB	O
demonstrated 	demonstrated 	 VBN	O
.  	.  	 .	O
Randomized 	Randomized 	 NNP	O
,  	,  	 ,	O
controlled  	controlled  	 VBN	B-NP
trials  	trials  	 NNS	I-NP
are  	are  	 VBP	O
needed  	needed  	 VBN	O
to  	to  	 TO	O
provide  	provide  	 VB	O
a  	a  	 DT	O
satisfactory  	satisfactory  	 JJ	B-NP
answer  	answer  	 NN	I-NP
on  	on  	 IN	O
this  	this  	 DT	O
issue 	issue 	 NN	O
.  	.  	 .	O
